Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations

    November 2022 in “ Life
    Afrin Yasmin, Shubhadeep Roychoudhury, Arun Paul Choudhury, A. B. Fuzayel Ahmed, Sulagna Dutta, Filomena Mottola, Vivek Verma, Jogen Chandra Kalita, Dhruv Kumar, Pallav Sengupta, Adriana Kolesárová
    TLDR PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.
    This systematic review provided an updated overview of Polycystic Ovary Syndrome (PCOS), focusing on the impacts of ethnic and geographic variations on its prevalence and clinical management. PCOS affected 8-13% of women of reproductive age and was associated with serious health risks like type 2 diabetes and infertility. The review highlighted inconsistencies in clinical symptoms based on ethnicity and geography, with indigenous women identified as high-risk populations. It emphasized the need for standardized diagnostic criteria and more research to understand PCOS's risk factors and prevalence. Management strategies included lifestyle modifications and pharmacological treatments, tailored to ethnic and regional differences. The document stressed early diagnosis and management to mitigate long-term metabolic risks.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 6 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    4 / 4 results